Free Trial
NASDAQ:PRTG

Portage Biotech (PRTG) Stock Price, News & Analysis

Portage Biotech logo
$7.38 +0.02 (+0.20%)
As of 03:17 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Portage Biotech Stock (NASDAQ:PRTG)

Key Stats

Today's Range
$7.27
$7.45
50-Day Range
$5.29
$9.97
52-Week Range
$2.81
$23.01
Volume
6,597 shs
Average Volume
575,026 shs
Market Capitalization
$7.74 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Portage Biotech Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
32nd Percentile Overall Score

PRTG MarketRank™: 

Portage Biotech scored higher than 32% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    There is not enough analysis data for Portage Biotech.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Portage Biotech is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Portage Biotech is -0.18, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Portage Biotech's valuation and earnings.
  • Percentage of Shares Shorted

    4.43% of the float of Portage Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Portage Biotech has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Portage Biotech has recently decreased by 26.67%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Portage Biotech does not currently pay a dividend.

  • Dividend Growth

    Portage Biotech does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    4.43% of the float of Portage Biotech has been sold short.
  • Short Interest Ratio / Days to Cover

    Portage Biotech has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Portage Biotech has recently decreased by 26.67%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Portage Biotech has a news sentiment score of 1.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.99 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Portage Biotech this week, compared to 0 articles on an average week.
  • Search Interest

    1 people have searched for PRTG on MarketBeat in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Portage Biotech insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    42.07% of the stock of Portage Biotech is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 13.36% of the stock of Portage Biotech is held by institutions.

  • Read more about Portage Biotech's insider trading history.
Receive PRTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Portage Biotech and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

PRTG Stock News Headlines

Amazon’s big Bitcoin embarrassment
Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. While the crowd buys Bitcoin outright, trader Larry Benedict is using a method called “Bitcoin Skimming” to target 6x, 9x, even 22x bigger profits. He reveals how it works in a free video.tc pixel
PRTG Portage Biotech Inc. - Seeking Alpha
Portage Biotech Regains Nasdaq Compliance
Portage Biotech Inc. (PRTG) Cash Flow - Yahoo Finance
See More Headlines

PRTG Stock Analysis - Frequently Asked Questions

Portage Biotech's stock was trading at $5.17 on January 1st, 2025. Since then, PRTG shares have increased by 42.6% and is now trading at $7.3750.

Portage Biotech Inc. (NASDAQ:PRTG) announced its earnings results on Tuesday, November, 26th. The company reported ($1.26) EPS for the quarter.

Shares of Portage Biotech reverse split on Thursday, August 15th 2024.The 1-20 reverse split was announced on Tuesday, August 13th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, August 14th 2024. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

Shares of PRTG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Portage Biotech investors own include Meta Platforms (META), Alimera Sciences (ALIM), Angion Biomedica (ANGN), AirMedia Group (ANTE), Broadcom (AVGO), Barnwell Industries (BRN) and Crescent Biopharma (CBIO).

Company Calendar

Last Earnings
11/26/2024
Today
8/28/2025
Next Earnings (Estimated)
9/03/2025
Fiscal Year End
3/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PRTG
CIK
1095435
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
2.02
Quick Ratio
2.02

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.79) per share
Price / Book
-9.32

Miscellaneous

Outstanding Shares
1,050,000
Free Float
608,000
Market Cap
$7.73 million
Optionable
Optionable
Beta
0.24
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

This page (NASDAQ:PRTG) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners